Prelude Capital Management, LLC Stereotaxis, Inc. Transaction History
Prelude Capital Management, LLC
- $1.12 Billion
- Q3 2025
A detailed history of Prelude Capital Management, LLC transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 17,394 shares of STXS stock, worth $38,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,394
Previous 31,943
45.55%
Holding current value
$38,440
Previous $67,000
20.9%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding STXS
# of Institutions
112Shares Held
43MCall Options Held
13.8KPut Options Held
31.4K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$30.2 Million11.38% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.71MShares$10.4 Million8.41% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$7.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$7.6 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$6.31 Million10.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $165M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...